In the Press
November 23, 2020
3 Firms Direct SPAC Deal Forming $2B Software Developer (Law360)
New Jersey-based AvePoint has agreed to merge with a special purpose acquisition company to create a single software developer valued at about $2 billion in a deal built by a Goodwin SPACs and Technology team. Read the Law360 article here.
Related Content
- NewslettersSeptember 4 – September 17, 2026
Agencies Propose Revisions to Third-Party Risk Management Guidance
- NewslettersAugust 31 – September 10, 2026
SEC Issues Proposal to Update Regulation of Transfer Agents
- NewslettersAugust 21 – September 3, 2026
FDIC and OCC Issue Final Rule Defining “Unsafe or Unsound Practice” and Establishing Standards for Issuing Matters Requiring Attention
- AlertSeptember 2, 2026
When the Safe Harbor Is Not Safe: Court of Chancery Weighs in on Amended Section 144 in Dodiya v. Franklin
- NewslettersAugust 17 – August 27, 2026
SEC to Cease Responding to No-Action Requests on Rule 14a-8 Shareholder Proposal Exclusions
- NewslettersAugust 7 – August 20, 2026
Treasury Proposes Rules Regarding the Issuance, Offering, and Sale of Payment Stablecoins
- NewslettersAugust 1 – August 14, 2026
SEC Announces Formation of Specialized Unit Within Division of Enforcement to Combat Accounting and Financial Reporting Fraud
- NewslettersJuly 24 – August 6, 2026
Federal Reserve Proposes Modernized Rules for Mutual Banking Organizations
- Press ReleaseSeptember 22, 2026
Goodwin Advises Softcat on $1.05 Billion Acquisition of GDT
- Press ReleaseSeptember 21, 2026
Goodwin Advises Console on Acquisition by Palo Alto Networks to Advance Agentic Capabilities
- Press ReleaseSeptember 17, 2026
Goodwin Advises Marea Therapeutics on Acquisition by Lisata Therapeutics and $225 Million Concurrent Private Placement
- Market RecognitionSeptember 17, 2026
Four Goodwin Partners Named to Forbes’ 2026 Top 250 Lawyers in America List
- Press ReleaseSeptember 2, 2026
Goodwin Strengthens Life Sciences and Public M&A Platform With Partner Ro Park
- Press ReleaseAugust 31, 2026
Goodwin Advises Merida Biosciences in up to $2.875 Billion Acquisition by Eli Lilly
- Market RecognitionAugust 24, 2026
Goodwin Earns Top Spot for Global M&A in H1 2026 League Tables
- In the PressAugust 20, 2026
AstraZeneca May Keep Chasing Transformative M&A or Merger After Abandoned BMS Deal (Mergermarket)